These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1517501)

  • 1. Toxic epidermal necrolysis in early infancy.
    Scully MC; Frieden IJ
    J Am Acad Dermatol; 1992 Aug; 27(2 Pt 2):340-4. PubMed ID: 1517501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nine years of a single referral center management of Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome).
    Monteiro D; Egipto P; Barbosa J; Horta R; Amarante J; Silva P; Silva A
    Cutan Ocul Toxicol; 2017 Jun; 36(2):163-168. PubMed ID: 27487073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Rare Case Report of Toxic Epidermal Necrolysis Due to Ofloxacin.
    Vaghela JJ; Nimbark VN; Chavda BC; Mehta HH; Purohit BM
    Curr Drug Saf; 2018; 13(2):137-140. PubMed ID: 29506464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toxic epidermal necrolysis in a 6-week-old infant.
    Hawk RJ; Storer JS; Daum RS
    Pediatr Dermatol; 1985 Mar; 2(3):197-200. PubMed ID: 3887341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK; Tay YK
    Acta Derm Venereol; 2012 Jan; 92(1):62-6. PubMed ID: 21710108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Harr T; French LE
    Chem Immunol Allergy; 2012; 97():149-66. PubMed ID: 22613860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stevens Johnson syndrome-Toxic Epidermal Necrolysis Overlap induced by sulfasalazine treatment: a case report.
    Zizi N; Elmrahi A; Dikhaye S; Fihmi N; Alami Z
    Tunis Med; 2015 Jul; 93(7):413-5. PubMed ID: 26757493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
    La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
    Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of the experience with paediatric patients in a university hospital.
    Ferrándiz-Pulido C; García-Fernández D; Domínguez-Sampedro P; García-Patos V
    J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1153-9. PubMed ID: 21198948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linear IgA bullous disease presenting as toxic epidermal necrolysis: a case report and review of the literature.
    Kakar R; Paugh H; Jaworsky C
    Dermatology; 2013; 227(3):209-13. PubMed ID: 24135381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxic epidermal necrolysis due to antiepileptic therapy in an 8-year-old boy.
    Muhar U; Granditsch G; Diem E
    Pediatr Dermatol; 1985 Nov; 3(1):54-8. PubMed ID: 4070087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe flucloxacillin-induced acute generalized exanthematous pustulosis (AGEP), with toxic epidermal necrolysis (TEN)-like features: does overlap between AGEP and TEN exist? Clinical report and review of the literature.
    van Hattem S; Beerthuizen GI; Kardaun SH
    Br J Dermatol; 2014 Dec; 171(6):1539-45. PubMed ID: 24888401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
    van der Meer JB
    Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
    [No Abstract]   [Full Text] [Related]  

  • 14. A 2-year-old girl with Stevens--Johnson syndrome/toxic epidermal necrolysis treated with intravenous immunoglobulin.
    Arca E; Köse O; Erbil AH; Nişanci M; Akar A; Gür AR
    Pediatr Dermatol; 2005; 22(4):317-20. PubMed ID: 16060867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review.
    Wong A; Malvestiti AA; Hafner Mde F
    Rev Assoc Med Bras (1992); 2016; 62(5):468-73. PubMed ID: 27656858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Piperacillin-tazobactam-induced linear IgA bullous dermatosis presenting clinically as Stevens-Johnson syndrome/toxic epidermal necrolysis overlap.
    Adler NR; McLean CA; Aung AK; Goh MS
    Clin Exp Dermatol; 2017 Apr; 42(3):299-302. PubMed ID: 28084616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic epidermal necrolysis in children--an update.
    Ringheanu M; Laude TA
    Clin Pediatr (Phila); 2000 Dec; 39(12):687-94. PubMed ID: 11156065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 27 years of a single burn centre experience with Stevens-Johnson syndrome and toxic epidermal necrolysis: analysis of mortality risk for causative agents.
    Weinand C; Xu W; Perbix W; Lefering R; Maegele M; Rathert M; Spilker G
    Burns; 2013 Nov; 39(7):1449-55. PubMed ID: 23702222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.
    Saka B; Barro-Traoré F; Atadokpédé FA; Kobangue L; Niamba PA; Adégbidi H; Yedomon HG; Traoré A; Pitché VP
    Int J Dermatol; 2013 May; 52(5):575-9. PubMed ID: 23330601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dermatologic emergencies.
    Usatine RP; Sandy N
    Am Fam Physician; 2010 Oct; 82(7):773-80. PubMed ID: 20879700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.